Maximum quantity allowed is 999
CAS RN: 128625-52-5 | 产品编码: R0296
Reagents for Condensation Reactions (1H-Benzotriazol-1-yloxytripyrrolidinophosphonium Hexafluorophosphate) (HPMC encapsulated)
* 无具体发货日期的情况,如:显示“8个工作日后发货”,将在您订购日起的8个工作日后发货。
* 我们将以最优方式从上海/天津两大仓库发货。国内库存不足,需两周左右向日本总部调货。
* 对于可分装产品,11:30前的订单,当天发货;11:30后的订单,隔天发货。
* 如需大包装,请点击“大包装询价”按钮(对于某些产品我们无法提供大包装)。
* TCI会经常复审储藏条件以对其进行优化,请以在线目录为准,敬请留意。
* 更多信息,请联系营业部:021-67121386 / Sales-CN@TCIchemicals.com 。任何货期、规格或包装方面的需求,请联系我们 。
补充产品信息:
Contents (per one capsule)
- 1H-Benzotriazol-1-yloxytripyrrolidinophosphonium Hexafluorophosphate : ca. 0.25 mmol
Directions for Use
- Each capsule contains all reagents for a single use on 0.25 mmol scale condensation reaction (amide coupling reaction) between carboxylic acid and amine.
Typical condition: 0.25 mmol of carboxylic acid and 1.25 equiv. of amines and 2.0 equiv. of base in DMF (0.25 M) at 30 °C.
Related Products
- B1774 1H-Benzotriazol-1-yloxytripyrrolidinophosphonium Hexafluorophosphate
产品编码 | R0296 |
分子式/分子量 | C__1__8H__2__8F__6N__6OP__2 = 520.40 |
外观与形状(20°C) | 固体 |
储存温度 | 冷藏 (0-10°C) |
应避免的情况 | 加热 |
CAS RN | 128625-52-5 |
Appearance | White to Almost white capsule |
Functionality test (conversion ratio) | min. 95.0 % |
象形图 | |
信号词 | 警告 |
危险性说明 | H302 : 吞咽有害。 H317 : 可能造成皮肤过敏反应。 H410 : 对水生生物毒性极大并具有长期持续影响。 |
防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P261 : 避免吸入粉尘。 P273 : 避免释放到环境中。 P272 : 受沾染的工作服不得带出工作场地。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P391 : 收集溢出物。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P333 + P313 : 如发生皮肤刺激或皮疹:求医/就诊。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。 |
新化学物质备案回执号 | B1A232215398 |
UN编号 | UN3077 |
类别 | 9 |
包装类别 | III |
监管条件代码(*) |
-
Used Chemicals
-
Procedure
-
Reagents for condensation capsule (1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate) (one capsule) was added to a solution of 4-bromobenzoic acid (40 mg, 0.20 mmol, 1.0 eq.) and morpholine (17 μL, 0.20 mmol, 1.25 eq.) in DMF (1 mL) at room temperature and the mixture was stirred for 2 hours. The reaction solution was diluted with ethyl acetate (5 mL) and filtered through Celite. The organic layer was washed with 1 mol/L HCl aq. (5 mL), sat. NaHCO3 aq. (5 mL) and brine (20 mL), dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (hexane: ethyl acetate = 1:1 - 1:2) to afford (4-bromophenyl)(morpholino)methanone (65 mg, 97% yield) as a white solid.
-
Experimenter’s Comments
-
The reaction mixture was monitored by UPLC.
The shape of the capsule is like below image and each capsule includes 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (ca. 0.25 mmol).
The material of the capsule is water-soluble HPMC (hydroxypropyl methylcellulose).
-
Analytical Data
-
(4-Bromophenyl)(morpholino)methanone
1H NMR (400 MHz, CDCl3); δ 7.57 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 3.74-3.44 (m, 8H).
-
Lead Reference
-
- Hydrophobic Pockets of HPMC Enable Extremely Short Reaction Times in Water
-
Other Reference
-
- HPMC: A Biomass-Based Semisynthetic Sustainable Additive Enabling Clean and Fast Chemistry in Water
化学品安全说明书(SDS)
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
示例 CoA
目前没有该产品的 CoA 示例。
分析图谱
很抱歉,您搜索的分析图谱无法提供。